Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1041 Neoplasms 872 Prostatic Neoplasms 506 Lung Neoplasms 421 Colorectal Neoplasms 357 Motor Activity 219 Head and Neck Neoplasms 194 Uterine Cervical Neoplasms 189 Carcinoma, Non-Small-Cell Lung 180 Brain Neoplasms 173 Pancreatic Neoplasms 160 Ovarian Neoplasms 138 Colonic Neoplasms 137 Carcinoma, Hepatocellular 136 Anxiety Disorders 124 Rectal Neoplasms 117 Hematologic Neoplasms 114 Multiple Myeloma 106 Stomach Neoplasms 103 Neoplasm Metastasis 99 Precursor Cell Lymphoblastic Leukemia-Lymphoma 94 Melanoma 92 Depression 92 Urinary Bladder Neoplasms 88 Pain 87 Endometrial Neoplasms 86 Glioblastoma 84 Disease 83 Lymphoma 81 Sarcoma 78

Interventions

Darbepoetin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Primary Care × 1 year × Clear all

NCT07130487 2025-11-25

Project CARE: CAncer Risk Evaluation

Rutgers, The State University of New Jersey

Phase NA Recruiting

Primary Care

Data powered by HemOnc (CC BY 4.0) Colophon ⚡